Cite

HARVARD Citation

    Migden, M. et al. (2020). Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet oncology. 21 (2), pp. 294-305. [Online]. 
  
Back to record